Online inquiry

ChIRP based RNA-Protein Interaction Analysis Service

Overview Services Applications Get Started FAQs Products

Mapping Spatial RNA Regulatory Landscapes with Precision

At Creative Biolabs, we leverage cutting-edge ChIRP (Chromatin Isolation by RNA Purification) technology to decode the intricate spatial interactions between non-coding RNAs and their protein partners across the genome. Designed exclusively for preclinical research, our platform integrates proprietary hybridization capture, high-resolution sequencing, and AI-driven bioinformatics to deliver unparalleled insights into RNA-centric regulatory networks in disease biology, epigenetics, and target discovery.

Technology Overview: The ChIRP Advantage

ChIRP targets endogenous RNA molecules using tiled, biotinylated antisense oligonucleotides, enabling ultra-specific isolation of RNA-protein-chromatin complexes. This approach overcomes the limitations of traditional methods through:

  • Spatial Specificity: Direct capture of architectural RNAs (e.g., lncRNAs, circRNAs) within native chromatin contexts.
  • Multi-Omic Resolution: Simultaneous mapping of RNA-protein interactions and chromatin occupancy.
  • Ultra-Low Background: Stringent washing eliminates non-specific binding, validated via scramble-oligo controls.

Featured Services

End-to-End Solutions - Comprehensive Service Offerings

Delivering modular, hypothesis-driven research packages to help you decode RNA-centric regulatory architectures.

  • Endogenous Complex Isolation Service

We offer comprehensive support to capture native RNA-chromatin-protein interactions in situ, solving the critical challenge of preserving transient biological states. Our optimized workflows enable researchers to map physiological complexes with spatial fidelity, bringing unprecedented clarity to RNA-centric regulatory mechanisms.

  • Architectural RNA Mapping Solutions

We deliver end-to-end expertise in profiling structural non-coding RNAs (e.g., scaffolding lncRNAs), addressing the technical hurdles of low-abundance target isolation. By implementing species-specific hybridization strategies, we help clients decode 3D genome organization mechanisms, accelerating discoveries in nuclear architecture and epigenetic reprogramming. This advances fundamental research in development and oncology.

  • Dynamic Network Analysis Support

Our team provides specialized solutions for tracking RNA interactome rewiring across time-series or perturbation conditions. We overcome the limitations of static snapshots through rigorous longitudinal designs, enabling clients to reconstruct dynamic regulatory cascades in differentiation, stress response, or drug treatment models. This reveals transient therapeutic vulnerabilities inaccessible through conventional approaches.

Fig.1 ChIRP Service Workflow. (Creative Biolabs Authorized)Fig.1 ChIRP Service Workflow.

Advanced Bioinformatics

Our customizable analytical framework provides scalable computational insights:

Analysis Tier Deliverables
RNA-Chromatin Hubs Identification of topologically associating domains (TADs) anchored by target RNAs; enhancer-promoter loop mapping
Functional Annotation Integration with ENCODE/TCGA datasets; pathway enrichment
3D Network Modeling Visualization of RNA-protein-chromatin interactomes; cooperative regulator identification
Disease Context Correlation with disease-associated SNPs; survival impact analysis in public cohorts

Related RNA-Protein Interaction Services

RIP-Seq Based Analysis

  • Native Complex Profiling: Physiological RBP interactions identified without crosslinking artifacts
  • Transcriptome-Wide Screening: Genome-scale mapping of steady-state RNA-protein associations
  • RBP Network Discovery: Foundational analysis for regulatory mechanism hypotheses

CLIP-Seq Based Analysis

  • Crosslink-Captured Interactions: Covalent stabilization of transient RNA-protein complexes
  • Single-Nucleotide Resolution: High-precision binding site localization
  • Dynamic Interaction Modeling: Temporal regulation analysis of RBP activity

RAP Based Analysis

  • Endogenous Complex Capture: In vivo preservation of native RNA-protein topologies
  • Comprehensive Interactomes: System-wide identification of direct/indirect interactors
  • Functional Module Discovery: Deconvolution of cooperative regulatory units

mRNA Interactome Capture

  • Translatome Profiling: Global snapshot of mRNA-bound proteomes
  • RBP Activity Benchmarking: Basal interaction network establishment
  • Translational Machinery Analysis: Ribosome-associated factor characterization

Emerging Research Applications

1. lncRNA in 3D Genome Organization

  • Architectural RNA Mechanisms
    Recent studies demonstrate how Xist and NEAT1 lncRNAs scaffold nuclear compartments, with spatial disruption linked to oncogenic gene activation.
  • CRISPR-Guided Perturbation
    Combining ChIRP with dCas9-mediated lncRNA knockdown reveals compensatory chromatin rewiring in stem cell differentiation models.

2. Viral RNA-Host Interfaces

  • Latency Regulation
    ChIRP-MS uncovered how Kaposi's sarcoma-associated herpesvirus (KSHV) lncRNA PAN recruits host ubiquitin ligases to evade immune surveillance.
  • Therapeutic Target Screening
    High-throughput ChIRP identifies host dependency factors bound by SARS-CoV-2 regulatory RNAs.

3. Cancer Epigenetic Reprogramming

  • Oncogenic lncRNA Circuits
    Integrated analysis of PVT1 revealed its role in stabilizing MYC protein at enhancer clusters, promoting chemoresistance in PDAC.
  • Metastatic Niche Remodeling
    Tumor-derived lncRNAs (e.g., MALAT1) hijack nuclear matrix proteins to alter collagen architecture in pre-metastatic lungs.

4. Neurodevelopmental Dynamics

  • Imprinted Loci Regulation
    Single-cell ChIRP uncovered cell-type-specific allelic silencing by Kcnq1ot1 lncRNA during cortical development.
  • Phase Separation Pathology
    Aberrant FUS-RNA granules disrupt chromatin compartmentalization in ALS models, detectable via ChIRP-imaging fusion.

Partner with Creative Biolabs

Why Choose Us?

Deep Expertise

  • 10+ years pioneering spatial RNA interactome research.
  • We've successfully delivered 50+ non-coding RNA projects, empowering breakthroughs in nuclear architecture and disease mechanisms.

Innovation Leadership

  • Proprietary approaches for unprecedented resolution.
  • Overcome limitations of traditional methods with our optimized platform designed for complex biological contexts.

Pure Research Integrity

  • 100% preclinical focus with zero therapeutic claims.
  • Your data is generated under strict research ethics guidelines, ensuring publication-ready integrity.

Initiate Your Project

Share your target RNA, biological model (cell lines, organoids, or tissues), and research goals. Our specialists will provide:

  • Customized oligo design strategy
  • Tissue-specific protocol optimization
  • Multi-omic integration roadmap

[Contact Us] Schedule a technical consultation within 24 hrs.

FAQs

Q1: How does ChIRP differ from CLIP-Seq?

A: ChIRP targets endogenous RNAs without antibodies, capturing RNA-chromatin-protein ternary complexes, while CLIP-Seq focuses on protein-centric RNA binding.

Q2: Can ChIRP analyze low-abundance lncRNAs?

A: Yes. Our signal amplification workflow detects RNAs at ≥5 copies/cell.

Q3: What sample types are compatible?

A: Cultured cells (≥2M), fresh/frozen tissues (≥20mg), FFPE sections. Species-agnostic.

Q4: Can functional validation be integrated?

A: Yes. Our platform supports combination with targeted gene editing systems to interrogate regulatory node functionality, enabling hypothesis-driven mechanistic studies.

Featured mRNA Products

Reference

  1. Mi, Xuelong, et al. "Fast, accurate, and versatile data analysis platform for the quantification of molecular spatiotemporal signals." Cell 188.10 (2025): 2794-2809. Distributed under Open Access license CC BY-NC 4.0, without modification. https://doi.org/10.1016/j.cell.2025.03.012
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.